TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
0.7430
-0.0127 (-1.68%)
At close: Jul 31, 2026, 4:00 PM EDT
0.7486
+0.0056 (0.75%)
After-hours: Jul 31, 2026, 7:34 PM EDT
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $48.56 million as of July 31, 2026. Its market cap has decreased by -52.60% in one year.
Market Cap
48.56M
Enterprise Value
13.04M
1-Year Change
-52.60%
Ranking
Category
Stock Price
$0.74
ChartMarket Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $48.56M, a decrease of -86.48%. That is a compound annual growth rate of -32.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 48.56M | -14.44% |
| Dec 31, 2025 | 56.75M | -66.96% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
| Jul 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MiNK Therapeutics | 52.31M |
| Filana Therapeutics | 48.79M |
| Instil Bio | 48.29M |
| aTyr Pharma | 47.62M |
| Immutep | 47.59M |
| BeyondSpring | 47.29M |
| Seres Therapeutics | 46.77M |
| INmune Bio | 46.52M |